These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 3494282

  • 1. The pharmacologic control of mediator release from human basophils and mast cells.
    Peters SP, Naclerio RM, Schleimer RP, MacGlashan DW, Pipkorn U, Lichtenstein LM.
    Respiration; 1986; 50 Suppl 2():116-22. PubMed ID: 3494282
    [Abstract] [Full Text] [Related]

  • 2. Disassociation of the release of histamine and arachidonic acid metabolites from osmotically activated basophils and human lung mast cells.
    Eggleston PA, Kagey-Sobotka A, Proud D, Adkinson NF, Lichtenstein LM.
    Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):960-4. PubMed ID: 1691604
    [Abstract] [Full Text] [Related]

  • 3. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
    Columbo M, Horowitz EM, Botana LM, MacGlashan DW, Bochner BS, Gillis S, Zsebo KM, Galli SJ, Lichtenstein LM.
    J Immunol; 1992 Jul 15; 149(2):599-608. PubMed ID: 1378071
    [Abstract] [Full Text] [Related]

  • 4. Generation of leukotriene C4, leukotriene B4, and prostaglandin D2 by immunologically activated rat intestinal mucosa mast cells.
    Heavey DJ, Ernst PB, Stevens RL, Befus AD, Bienenstock J, Austen KF.
    J Immunol; 1988 Mar 15; 140(6):1953-7. PubMed ID: 2450136
    [Abstract] [Full Text] [Related]

  • 5. Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells.
    Schleimer RP, Schulman ES, MacGlashan DW, Peters SP, Hayes EC, Adams GK, Lichtenstein LM, Adkinson NF.
    J Clin Invest; 1983 Jun 15; 71(6):1830-5. PubMed ID: 6134755
    [Abstract] [Full Text] [Related]

  • 6. Characterization of inflammatory mediator release from purified human lung mast cells.
    Schleimer RP, MacGlashan DW, Peters SP, Pinckard RN, Adkinson NF, Lichtenstein LM.
    Am Rev Respir Dis; 1986 Apr 15; 133(4):614-7. PubMed ID: 3485946
    [Abstract] [Full Text] [Related]

  • 7. Differential modulation of mediator release from human basophils and mast cells by mizolastine.
    Triggiani M, Giannattasio G, Balestrieri B, Granata F, Gelb MH, de Paulis A, Marone G.
    Clin Exp Allergy; 2004 Feb 15; 34(2):241-9. PubMed ID: 14987304
    [Abstract] [Full Text] [Related]

  • 8. Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell.
    Undem BJ, Peachell PT, Lichtenstein LM.
    J Pharmacol Exp Ther; 1988 Oct 15; 247(1):209-17. PubMed ID: 2459368
    [Abstract] [Full Text] [Related]

  • 9. Modulation of the release of histamine and arachidonic acid metabolites from human basophils and mast cells by auranofin.
    Marone G, Columbo M, Galeone D, Guidi G, Kagey-Sobotka A, Lichtenstein LM.
    Agents Actions; 1986 Apr 15; 18(1-2):100-2. PubMed ID: 2425566
    [Abstract] [Full Text] [Related]

  • 10. Human basophil/mast cell releasability. VII. Heterogeneity of the effect of adenosine on mediator secretion.
    Marone G, Cirillo R, Genovese A, Marino O, Quattrin S.
    Life Sci; 1989 Apr 15; 45(19):1745-54. PubMed ID: 2480501
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of IgE-mediated release of histamine and peptide leukotriene from human basophils and mast cells by forskolin.
    Marone G, Columbo M, Triggiani M, Cirillo R, Genovese A, Formisano S.
    Biochem Pharmacol; 1987 Jan 01; 36(1):13-20. PubMed ID: 2432900
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Control mechanisms of mediator release in human basophils and mast cells.
    Marone G.
    Immunol Invest; 1988 Jan 01; 17(8-9):707-45. PubMed ID: 2465995
    [No Abstract] [Full Text] [Related]

  • 19. Mediator release from human lung under conditions of reduced oxygen tension.
    Peters SP, Lichtenstein LM, Adkinson NF.
    J Pharmacol Exp Ther; 1986 Jul 01; 238(1):8-13. PubMed ID: 2425080
    [Abstract] [Full Text] [Related]

  • 20. The pharmacologic modulation of the release of arachidonic acid metabolites from purified human lung mast cells.
    Peters SP, MacGlashan DW, Schleimer RP, Hayes EC, Adkinson NF, Lichtenstein LM.
    Am Rev Respir Dis; 1985 Aug 01; 132(2):367-73. PubMed ID: 3927806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.